Complete remission induced by high dose erythropoietin and granulocyte colony stimulating factor in acute erythroleukemia (AML-M6 with maturation)
Camera, A.; Volpicelli, M.; Villa, M.R.; Risitano, A.M.; Rossi, M.; Rotoli, B.
Haematologica 87(11): 1225-1227
2002
ISSN/ISBN: 0390-6078 PMID: 12414355 Document Number: 551498
Alternative therapeutic approaches with low dose chemotherapy and differentiative-maturative treatment by growth factors are under consideration for elderly patients with acute leukemia. Two patients with AML-M6 with maturation, one refractory to standard chemotherapy and the other ineligible for cytoxic treatment, obtained complete remission from leukemia using high dose recombinant erythropoietin and granulocyte colony-stimulating factor.
Document emailed within 1 workday
Related Documents
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28Chang, J.M.; Johnson, G.R. 1991: Effects on spleen colony-forming unit self-renewal after retroviral-mediated gene transfer of multi-colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or granulocyte colony-stimulating factor Experimental Hematology 19(7): 602-607
Hsu, H.C.; Chiu, C.F.; Tan, T.D.; Chau, W.K.; Tseng, C.S.; Ho, C.H. 1995: Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report Zhonghua Yi Xue Za Zhi 56(5): 305-311
Shimoda, K.; Okamura, S.; Harada, N.; Ikematsu, W.; Kondo, S.; Kawasaki, C.; Tanaka, T.; Etou, T.; Akashi, K.; Okamura, T. 1992: Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors Cancer Research 52(11): 3052-3055
Sakashita, A.; Nakamaki, T.; Tsuruoka, N.; Honma, Y.; Hozumi, M. 1991: Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells Leukemia 5(1): 26-31
Osugi, Y.; Keisei, K.H.; Murayama, N.; Inoue, M.; Ishihara, S.; Hara, J.; Yagi, K.; Tawa, A.; Okada, S.; Izumi, Y. 1990: Effects of recombinant human granulocyte colony stimulating factor following high-dose cytosine arabinoside therapy in children with malignancy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(7): 1379-1382
Rosell, R.; Gómez-Codina, J.; Anton, A.; Sánchez, J.J.; Vadell, C. 1994: Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate Seminars in Oncology 21(1 Suppl 1: 48-53
Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192
Hazar, V.; Ongun, H.; Yeşilipek, M.A.; Yeğin, O. 1999: Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome Turkish Journal of Pediatrics 41(1): 117-120
Chanson, P.; Pariente, A. 2015: Combination of granulocyte colony-stimulating factor and erythropoietin in decompensated cirrhosis: a positive essay? La Revue du Praticien 65(4): 472-473
Katayama, Y.; Kojima, K.; Omoto, E.; Harada, M. 1996: Androgen therapy in combination with granulocyte colony-stimulating factor and erythropoietin in a patient with refractory anemia International Journal of Hematology 65(1): 89-92
Yanagisawa, K.; Yano, A.; Takada, K.; Yasukawa, M.; Fujita, S. 1994: Increase of erythropoiesis and thrombopoiesis, and induction of remission by granulocyte colony-stimulating factor (G-CSF) in a patient with hypoplastic leukemia Leukemia 8(7): 1249-1251
Stahl, C.P.; Winton, E.F.; Monroe, M.C.; Holman, R.C.; Zelasky, M.; Liehl, E.; Myers, L.A.; McClure, H.; Anderson, D.; Evatt, B.L. 1991: Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates Experimental Hematology 19(8): 810-816
Schrader, J.W.; Moyer, C.; Ziltener, H.J.; Reinisch, C.L. 1991: Release of the cytokines colony-stimulating factor-1, granulocyte-macrophage colony-stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells Journal of Immunology 146(11): 3799-3808
Kelso, A.; Metcalf, D.; Gough, N.M. 1986: Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones Journal of Immunology 136(5): 1718-1725
Fujikawa, Y.; Sabokbar, A.; Neale, S.D.; Itonaga, I.; Torisu, T.; Athanasou, N.A. 2001: The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells Bone 28(3): 261-267
Vellenga, E.; Delwel, H.R.; Touw, I.P.; Löwenberg, B. 1987: Patterns of acute myeloid leukemia colony growth in response to recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) Experimental Hematology 15(6): 652-656
Suda, T.; Suda, J.; Kajigaya, S.; Nagata, S.; Asano, S.; Saito, M.; Miura, Y. 1987: Effects of recombinant murine granulocyte colony-stimulating factor on granulocyte-macrophage and blast colony formation Experimental Hematology 15(9): 958-965
Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37